Abstract

BackgroundPrevious literatures have implied that the liver fat deposition plays a crucial role in the development and progression of insulin resistance. In the present study, we aimed to investigate the association of liver fat content (LFC) with glucose metabolism status in the population of newly diagnosed type 2 diabetes mellitus (nT2DM), prediabetes mellitus (PDM) and normal controls (NC), and assessing if the LFC could as an indicator for the prediction of T2DM.MethodsA total of 242 subjects (including 141 nT2DM patients, 48 PDM subjects and 53 NC) were enrolled. The levels of LFC were quantified by using the proton magnetic resonance spectroscopy ([1H]-MRS) technique. Clinical and laboratory parameters of study subjects were collected by medical records and biochemical detection. One-way ANOVA or nonparametric test (Kruskal–Wallis) was applied for intergroup comparisons; intergroup comparison was performed in using of Bonferroni multiple-significance-test correction.ResultsThere were significantly increased LFC levels in nT2DM (14.72% ± 6.37%) than in PDM (9.62% ± 4.41%) and that of NC groups (5.11% ± 3.66%) (all p < 0.001). The prevalence of nonalcoholic fatty liver disease (NAFLD) was also found to be increased in nT2DM (91.48%) than in PDM (85.41%) and that of NC (32.07%) groups. Correlation analysis revealed that the increase of LFC positively associated with fast plasma glucose (FPG), 2 h plasma glucose (PG), Delta G30 and homeostatic model assessment of insulin resistance (HOMA-IR), negatively associated with Delta Ins30, Delta C30, Ins30/G30 AUC, CP30/G30 AUC, Ins AUC/G AUC, CP AUC/G AUC, homeostatic model assessment for β-cell function index (HOMA-β) and matsuda insulin sensitivity index (Matsuda ISI). Multilinear regression analysis showed that LFC, body mass index (BMI) and diastolic blood pressure (DBP) contributed for the prediction of HOMA-IR, and total cholesterol (TC), age, waist circumference (WC) and low-density lipoprotein cholesterol (LDL-C) were the significant contributors for HOMA-β.ConclusionsOur study revealed an increased LFC level and prevalence of NAFLD in nT2DM than in PDM and that of NC groups, the increase of LFC was closely associated with insulin resistance and impaired glucose metabolism status, may be regarded as potential indicator contributing to the development and progression of T2DM.

Highlights

  • Previous literatures have implied that the liver fat deposition plays a crucial role in the development and progression of insulin resistance

  • We could observe that the frequency of liver fat con‐ tent (LFC) among normal controls (NC), prediabetes mellitus (PDM) and newly diagnosed type 2 diabetes mellitus (nT2DM) groups mainly distributed in LFC of 0–5% (68.75%), LFC of 5–10% (41.54%) and LFC of 10–20% (53.81%), respectively

  • multivariate linear regression (MLR) to identify the contributors for HOMA‐IR and HOMA‐β First, homeostatic model assessment of insulin resistance (HOMA-IR) was set as dependent variable, independent variables of LFC and traditional risk factors were included in MLR model, the results indicated that body mass index (BMI), LFC and diastolic blood pressure (DBP) were the significant contributors that closely associated with HOMA-IR (Additional file 3: Table S2)

Read more

Summary

Introduction

Previous literatures have implied that the liver fat deposition plays a crucial role in the development and progression of insulin resistance. We aimed to investigate the association of liver fat con‐ tent (LFC) with glucose metabolism status in the population of newly diagnosed type 2 diabetes mellitus (nT2DM), prediabetes mellitus (PDM) and normal controls (NC), and assessing if the LFC could as an indicator for the prediction of T2DM. Type 2 diabetes mellitus (T2DM) is a complex, multifactorial, chronic metabolic disease characterized as insulin resistance and impaired pancreatic β-cell function [1, 2]. It has been disclosed that NAFLD associated with different types of diseases, such as obesity, diabetes, hypertension and metabolic syndrome [4,5,6,7]. In the past few years, emerging evidence has revealed that the association of NAFLD with an increased risk for T2DM and metabolic syndrome [9, 10]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call